首页> 美国卫生研究院文献>other >Design of the New York City Macroscope: Innovations in Population Health Surveillance Using Electronic Health Records
【2h】

Design of the New York City Macroscope: Innovations in Population Health Surveillance Using Electronic Health Records

机译:纽约市宏观范围的设计:使用电子健康记录进行人口健康监测的创新

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction:Electronic health records (EHRs) have the potential to offer real-time, inexpensive standardized health data about chronic health conditions. Despite rapid expansion, EHR data evaluations for chronic disease surveillance have been limited. We present design and methods for the New York City (NYC) Macroscope, an EHR-based chronic disease surveillance system.This methods report is the first in a three part series describing the development and validation of the NYC Macroscope. This report describes in detail the infrastructure underlying the NYC Macroscope; indicator definitions; design decisions that were made to maximize data quality; characteristics of the population sampled; completeness of data collected; and lessons learned from doing this work. The second report describes the methods used to evaluate the validity and robustness of NYC Macroscope prevalence estimates; presents validation results for estimates of obesity, smoking, depression and influenza vaccination; and discusses the implications of our findings for NYC and for other jurisdictions embarking on similar work. The third report applies the same validation methods to metabolic outcomes, including the prevalence, treatment and control of diabetes, hypertension and hyperlipidemia.
机译:简介:电子健康记录(EHR)有潜力提供有关慢性病的实时,廉价的标准化健康数据。尽管扩展迅速,用于慢性病监测的EHR数据评估仍然有限。我们介绍了基于EHR的慢性疾病监视系统纽约市(Macroscope)的设计和方法,该方法报告是由三部分组成的系列文章中的第一篇,描述了纽约市(Macroscope)的开发和验证。该报告详细描述了纽约市宏观范围的基础设施。指标定义;做出旨在最大化数据质量的设计决策;抽样人群的特征;所收集数据的完整性;以及从这项工作中学到的教训。第二份报告介绍了用于评估NYC Macroscope患病率估计值的有效性和稳健性的方法。提出验证结果,以估计肥胖,吸烟,抑郁和流感疫苗接种;并讨论了我们的调查结果对纽约市和其他进行类似工作的辖区的意义。第三份报告对代谢结果采用了相同的验证方法,包括糖尿病,高血压和高脂血症的患病率,治疗和控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号